Market Overview:
The global Bifidobacterium longum market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for probiotics and rising awareness about their benefits. In addition, the growing incidence of lifestyle diseases is also contributing to the growth of this market. Based on type, the global Bifidobacterium longum market can be segmented into 0.2g/piece and 0.25g/piece segments.
Product Definition:
Bifidobacterium longum is a type of bacteria that can be found in the intestines. It is commonly used as a probiotic, meaning it can help to improve gut health. Some research suggests that B. longum may help to improve symptoms of irritable bowel syndrome (IBS) and other digestive issues.
0.2g/Piece:
0.2g/piece is the minimal unit of weight for a single Bifidobacterium longum bacterium. It's usage in the market is growing at a significant rate owing to its benefits such as it helps in reducing diarrhea and constipation, boosting immunity, improving gut health and enhancing nutrient absorption among others. The product also has applications in pharmaceuticals which are expected to drive growth over the forecast period.
0.25g/Piece:
0.25g/piece is the standard weight of dry bifidobacterium longum bacteria and it can be used for both, indoor and outdoor cultivation. It is a good choice for new growers as well as experienced ones because it has been proven to have a significant effect on the yield of marijuana.
0.25g/piece contains about 109 viable bacteria cells which means that 109 bacterial cells are required to make one viable marijuana plant (1:10).
Application Insights:
The medicine segment held the largest share of over 70.0% in 2017. The growth can be attributed to the increasing use of bifidobacterium products for treating infant colic, constipation, diarrhea and gas among others. Bifidobacterium longum is considered as an ideal probiotic strain for infants on account of its high lactic acid production which helps in maintaining the balance of good bacteria in their intestinal tract.
Bifidobacterium longum is also used for dairy fermentation applications owing to its ability to produce cheese-like products from milk including yogurt and kefir when grown on lactose-free mediums such as corn or soybean meal respectively.
Regional Analysis:
Europe was the largest regional market in 2017 owing to high consumption of probiotics. The region is expected to maintain its dominance over the forecast period due to rising incidence of digestive disorders and growing awareness about health benefits of probiotics. Asia Pacific is projected to be the fastest-growing regional market from 2018 to 2030 due largely geographic expansion by global players coupled with increasing R&D activities for development of new strains and products.
The global market has been segmented into North America, Europe, Asia Pacific (APAC), Latin America (LATAM), and Middle East & Africa (MEA). LATAM held a significant share in 2017 as it is one of the emerging markets for dairy products which are majorly manufactured using bacterial fermentation techniques known as yogurt making.
Growth Factors:
- Increasing awareness about the benefits of probiotics: There is a growing awareness among people about the benefits of probiotics, which is driving the growth of the Bifidobacterium longum market.
- Rising demand for functional foods and dietary supplements: The demand for functional foods and dietary supplements that contain Bifidobacterium longum is increasing, thereby propelling the growth of this market.
- Growing number of research studies on probiotics: The number of research studies being conducted on probiotics is rising, which is resulting in an increase in their adoption by consumers worldwide. This will help to boost the growth prospects of the Bifidobacterium longum market in years to come.
- Rapid expansion of distribution channels: The distribution channels for probiotic products are expanding rapidly, providing a wider reach to consumers across different regions globally. This will aid in fuelling the growth trajectoryoftheBifidobacteriumlongummarketin future years too . 5
Scope Of The Report
Report Attributes
Report Details
Report Title
Bifidobacterium Longum Market Research Report
By Type
0.2g/Piece, 0.25g/Piece
By Application
Medicine, Others
By Companies
ATCC Inc, BioGaia AB, Mystic Pharmaceuticals Inc, Hanson Ltd, Biofodan A/S, BioCare Copenhagen ApS, Danisco A/S, Danone SA, Deerland Enzymes Inc., ATCC Inc
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Bifidobacterium Longum Market Report Segments:
The global Bifidobacterium Longum market is segmented on the basis of:
Types
0.2g/Piece, 0.25g/Piece
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Medicine, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- ATCC Inc
- BioGaia AB
- Mystic Pharmaceuticals Inc
- Hanson Ltd
- Biofodan A/S
- BioCare Copenhagen ApS
- Danisco A/S
- Danone SA
- Deerland Enzymes Inc.
- ATCC Inc
Highlights of The Bifidobacterium Longum Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 0.2g/Piece
- 0.25g/Piece
- By Application:
- Medicine
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bifidobacterium Longum Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bifidobacterium longum is a type of bacteria that is beneficial to the gut. It helps to promote a healthy digestive system by helping to break down food and absorb nutrients. Bifidobacterium longum can also help reduce inflammation in the gut, which can lead to improved overall health.
Some of the key players operating in the bifidobacterium longum market are ATCC Inc, BioGaia AB, Mystic Pharmaceuticals Inc, Hanson Ltd, Biofodan A/S, BioCare Copenhagen ApS, Danisco A/S, Danone SA, Deerland Enzymes Inc., ATCC Inc.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bifidobacterium Longum Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bifidobacterium Longum Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bifidobacterium Longum Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bifidobacterium Longum Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bifidobacterium Longum Market Size & Forecast, 2018-2028
4.5.1 Bifidobacterium Longum Market Size and Y-o-Y Growth
4.5.2 Bifidobacterium Longum Market Absolute $ Opportunity
Chapter 5 Global Bifidobacterium Longum Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Bifidobacterium Longum Market Size Forecast by Type
5.2.1 0.2g/Piece
5.2.2 0.25g/Piece
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Bifidobacterium Longum Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Bifidobacterium Longum Market Size Forecast by Applications
6.2.1 Medicine
6.2.2 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bifidobacterium Longum Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bifidobacterium Longum Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Bifidobacterium Longum Analysis and Forecast
9.1 Introduction
9.2 North America Bifidobacterium Longum Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Bifidobacterium Longum Market Size Forecast by Type
9.6.1 0.2g/Piece
9.6.2 0.25g/Piece
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Bifidobacterium Longum Market Size Forecast by Applications
9.10.1 Medicine
9.10.2 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Bifidobacterium Longum Analysis and Forecast
10.1 Introduction
10.2 Europe Bifidobacterium Longum Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Bifidobacterium Longum Market Size Forecast by Type
10.6.1 0.2g/Piece
10.6.2 0.25g/Piece
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Bifidobacterium Longum Market Size Forecast by Applications
10.10.1 Medicine
10.10.2 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Bifidobacterium Longum Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Bifidobacterium Longum Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Bifidobacterium Longum Market Size Forecast by Type
11.6.1 0.2g/Piece
11.6.2 0.25g/Piece
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Bifidobacterium Longum Market Size Forecast by Applications
11.10.1 Medicine
11.10.2 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Bifidobacterium Longum Analysis and Forecast
12.1 Introduction
12.2 Latin America Bifidobacterium Longum Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Bifidobacterium Longum Market Size Forecast by Type
12.6.1 0.2g/Piece
12.6.2 0.25g/Piece
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Bifidobacterium Longum Market Size Forecast by Applications
12.10.1 Medicine
12.10.2 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Bifidobacterium Longum Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Bifidobacterium Longum Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Bifidobacterium Longum Market Size Forecast by Type
13.6.1 0.2g/Piece
13.6.2 0.25g/Piece
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Bifidobacterium Longum Market Size Forecast by Applications
13.10.1 Medicine
13.10.2 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bifidobacterium Longum Market: Competitive Dashboard
14.2 Global Bifidobacterium Longum Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 ATCC Inc
14.3.2 BioGaia AB
14.3.3 Mystic Pharmaceuticals Inc
14.3.4 Hanson Ltd
14.3.5 Biofodan A/S
14.3.6 BioCare Copenhagen ApS
14.3.7 Danisco A/S
14.3.8 Danone SA
14.3.9 Deerland Enzymes Inc.
14.3.10 ATCC Inc
